Mortality within 30 days of chemotherapy: A clinical governance benchmarking issue for oncology patients

British Journal of Cancer

Volumn 95, Issue 12, 2006, Pages 1632-1636

  O'Brien, M E R ^a   Borthwick, A ^a   Rigg, A ^a   Leary, A ^a   Assersohn, L ^a   Last, K ^a   Tan, S ^a   Milan, S ^a   Tait, D ^a   Smith, I E ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Benchmark; Chemotherapy; Mortality

Indexed keywords

ANTINEOPLASTIC AGENT; INTERFERON; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DEATH; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; DRUG FATALITY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE QUALITY; HEMATOLOGIC MALIGNANCY; HOSPITAL; HUMAN; KIDNEY DISEASE; MALE; NEUTROPENIA; ONCOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SEPSIS; SOLID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BENCHMARKING; CAUSE OF DEATH; CHILD; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; MORTALITY; NEOPLASMS; TIME FACTORS;

EID: 33845671340     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603498     Document Type: Article

References (6)

1. Gomez H, Hidalgo M, Casanova L, Colomer R, Pen DL, Otero J, Rodriguez W, Carracedo C, Cortes-Funes H, Vallejos C (1998) Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. J Clin Oncol 16(6): 2065-2069
2. Kuciejewska A, Banerji U, Walsh G, Ashley S, O'Brien M, Johnston S, Smith I (2006) A study of factors determining outcome of patients receiving third line chemotherapy for metastatic breast cancer - the Royal Marsden Hospital Experience. J Clin Oncol 24(18s): 42s
3. Lunn JN, Mushin WW (1982) Mortality associated with anaesthesia. Anaesthesia 37(8): 856
4. Ohe Y, Yamamoto S, Suzuki K, Hojo F, Kakinuma R, Matsumoto T, Ohmatsu H, Nishiwaki Y (2001) Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer. Eur J Cancer 37(1): 54-63
5. Radford JA, Ryder WDJ, Dodwell D, Anderson H, Thatcher N (1993) Predicting septic complications of chemotherapy: An analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis. Eur J Cancer 29A(1): 81-86
6. Stephens RJ, Girling DJ, Machin D (1994) Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified? Medical Research Council Lung Cancer Working Party. Lung Cancer 11(3-4): 259-274